CAS 91147-07-8

Infractin

CAS : 91147-07-8

Infractin is a novel compound designed as a targeted therapeutic agent, which is synthetically derived. Its mode of action involves selectively modulating specific signaling pathways at the molecular level, primarily affecting inflammatory signaling cascades. By inhibiting key enzymes and receptors, Infractin effectively reduces the expression of pro-inflammatory cytokines and mediators.

Formule : C₁₅H₁₄N₂O₂

Degré de pureté : Min. 95%

Masse moléculaire : 254.28 g/mol

Ref: 3D-RDA14707